Thrombotic Microangiopathies with Rheumatologic Involvement

被引:19
作者
Babar, Faizan [1 ]
Cohen, Scott D. [1 ]
机构
[1] George Washington Univ, Dept Med, Div Renal Dis & Hypertens, 2150 Penn Ave, Washington, DC 20037 USA
关键词
Thrombotic microangiopathies; Systemic lupus erythematosus; Antiphospholipid antibody syndrome; Scleroderma; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SCLERODERMA RENAL CRISIS; CONNECTIVE-TISSUE DISEASES; VON-WILLEBRAND-FACTOR; COMPLEMENT FACTOR-H; LONG-TERM OUTCOMES; ANTIPHOSPHOLIPID SYNDROME; THROMBOCYTOPENIC PURPURA; ALTERNATIVE PATHWAY; CONSENSUS STATEMENT;
D O I
10.1016/j.rdc.2018.06.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombotic microangiopathies are heterogeneous disorders characterized by microangiopathic hemolytic anemia with thrombocytopenia and renal injury. There are a variety of causes, including metabolic disorders, infections, medications, complement disorders, pregnancy, malignancy, and autoimmune disorders. This article focuses on renal thrombotic micro-angiopathy in the setting of rheumatologic diseases. Systemic lupus erythematosus is the most common autoimmune disease associated with thrombotic microangiopathy. Other causes include scleroderma renal crisis and antiphospholipid antibody syndrome, which can be primary or secondary to autoimmune diseases, including systemic lupus erythematosus. There have also been case reports of thrombotic microangiopathy in the setting of rheumatoid arthritis and dermatomyositis.
引用
收藏
页码:635 / +
页数:17
相关论文
共 83 条
[1]  
[Anonymous], 1995, RENAL DIS CLASSIFICA
[2]   Scleroderma Renal Crisis in a Normotensive Patient [J].
Asamoah-Odei, Efua .
KIDNEY INTERNATIONAL REPORTS, 2016, 1 (04) :311-315
[3]   The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction [J].
Austin, S. K. ;
Starke, R. D. ;
Lawrie, A. S. ;
Cohen, H. ;
Machin, S. J. ;
Mackie, I. J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) :536-544
[4]   RENAL VASCULAR-LESIONS AS A MARKER OF POOR PROGNOSIS IN PATIENTS WITH LUPUS NEPHRITIS [J].
BANFI, G ;
BERTANI, T ;
BOERI, V ;
FARAGGIANA, T ;
MAZZUCCO, G ;
MONGA, G ;
SACCHI, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (02) :240-248
[5]   Complement Factor H Deficiency Accelerates Development of Lupus Nephritis [J].
Bao, Lihua ;
Haas, Mark ;
Quigg, Richard J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02) :285-295
[6]   Scleroderma Renal Crisis: A Pathology Perspective [J].
Batal, Ibrahim ;
Domsic, Robyn T. ;
Medsger, Thomas A., Jr. ;
Bastacky, Sheldon .
INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2010, 2010
[7]   Antiphospholipid syndrome and kidney disease [J].
Bienaime, Frank ;
Legendre, Christophe ;
Terzi, Fabiola ;
Canaud, Guillaume .
KIDNEY INTERNATIONAL, 2017, 91 (01) :34-44
[8]  
Canaud G, 2014, NEW ENGL J MED, V371, P1554, DOI [10.1056/NEJMoa1312890, 10.1056/NEJMc1410247]
[9]   Failure of losartan to control blood pressure in scleroderma renal crisis [J].
Caskey, FJ ;
Thacker, EJ ;
Johnston, PA ;
Barnes, JN .
LANCET, 1997, 349 (9052) :620-620
[10]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027